SU662009A3 - Способ получени производных пиперидина или их солей - Google Patents

Способ получени производных пиперидина или их солей

Info

Publication number
SU662009A3
SU662009A3 SU772534003A SU2534003A SU662009A3 SU 662009 A3 SU662009 A3 SU 662009A3 SU 772534003 A SU772534003 A SU 772534003A SU 2534003 A SU2534003 A SU 2534003A SU 662009 A3 SU662009 A3 SU 662009A3
Authority
SU
USSR - Soviet Union
Prior art keywords
piperidine
salts
piperidine derivatives
mol
obtaining
Prior art date
Application number
SU772534003A
Other languages
English (en)
Inventor
Фрибе Вальтер-Гунар (Фрг)
Тиль Макс (Фрг)
Штах Курт (Австрия)
Original Assignee
Берингер Маннхайм Гмбх (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Маннхайм Гмбх (Фирма) filed Critical Берингер Маннхайм Гмбх (Фирма)
Application granted granted Critical
Publication of SU662009A3 publication Critical patent/SU662009A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Description

Взаимодействие соединений общей формулы ( it ) с соединени ми общей формулы {щ ) целесообразно проводить в щелочной среде, например в низшем спирте, в присутствии гидроокиси или алкогол та щелочного металла при температуре от до температуры кипени  растворител . П р,и .м е р 1. 4-Фенрксиметилпнперидин . К смеси, состо щей из 28 мл 30%ного-раствора метилата натри , и 50 мл метанола, добавл ют 14,1 г (0,15 моль) фенола, затем упаривают в вакууме, смешивают с 50 мл N,N-диметилформамида и 7,8 г (0,05 моль гидрохлорида 4-хлорметилпиперидина и нагревают 18 ч при 70-80 С. После охлаждени  разбавл ют эфиром, промывают водой и )азбавленным раствором (гидроокиси натри , высушивают йадсульфатом натри  и упаривают- в вакууме . Получйют 3,1 г 4-феноксиметилпипёридина . Выход 32%, т.пл. 41-42 0 Испольэуе.мый в качестве исходного соединени  гидрохлорид 4-клОрМетилпиперидина получают следующим образо , к раствору 58 мл тионилхлорида в 250 мл хлороформа прибавл ют по капл м раствор 45 г (0,39 моль) 4-оксиметилпйперидина в 200 мл хлороформа . Смесь перемешивают в течение 1 чпри кип чении с обратным холодильником , упаривают в вакууме и растирают остаток с эфиром. Получают 54,2 г гидрохлорида 4-хло метилпиперидина . Выход 88%, т,пл. f30-132 C. Пример 2. 4-(2-Нитрофеноксиметил )-пиперидин. Смесь, состо щую из 23,0 г (0,2 моль) 4-оксиметилпиперидина, 31,5 г (0,2 моль) 2-хлорнитробензола, 11,8 г (0,21 моль) гидроокиси ксши  и 200 мл диоксана, нагревают 3 дн  при 70°С, затем упаривают в вакууме, раствор ют остаток в эфире, прогвлвают водой, экстрагируют разбавленной сол ной кислотой, подщелачивают экстракт и экстрагируют водную смесь эфиром. После упаривани  растворител  получают 10,5 г 4-(2-нитрофеноксиметил )-пиперидина. Выход 22%, т.кип. 130-132 С/0,01 мм рт.ст. Аналогично примеру 1 получают целевые продукты, приёеденные в таблице.v
4-(2-Бромфеноксиметил)-пиперидин . , ::
4-(2-Хлорфеноксиметил)-пиперидии , ,
4-(3-Хлорфеноксиметил)-пипе
ридин
4-(2-Фторфеноксиметил)-пиперидин
.4-(4-Фторфеноксиметил)-пиперидин
4-(2-Метбксифеноксиметил)-пипридин .
4-(3-Метоксифеноксиметил)-пиперидин .
4-(4-Метоксифеноксиметил)-пип ридин
4-(2-Бутоксифеноксиметил)-пипридин
4-(2-Метилфеноксиметил)-пиперидин
4 (4-Метилфеноксиметил) -пиперидин
48-50
35-37
4-(4-Метилфе оксиметил)-пиперидин
4-(2-н-Пропилфеноксиметил)-пиперидин
4-(2-Этилфеноксиметил)-пиперидин
(2-Бутил)-феноксиметил -пиперидин

Claims (1)

1. Вейганд-Хильгетаг Методы эксперимента в орзганической химии . М., Хими , 1968, с. 333-340.
SU772534003A 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей SU662009A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SU662009A3 true SU662009A3 (ru) 1979-05-05

Family

ID=5961166

Family Applications (3)

Application Number Title Priority Date Filing Date
SU762415648A SU633473A3 (ru) 1975-11-07 1976-11-02 Способ получени производных пиперидина или их солей
SU772534004A SU867298A3 (ru) 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей
SU772534003A SU662009A3 (ru) 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SU762415648A SU633473A3 (ru) 1975-11-07 1976-11-02 Способ получени производных пиперидина или их солей
SU772534004A SU867298A3 (ru) 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей

Country Status (20)

Country Link
US (1) US4243807A (ru)
JP (1) JPS6055509B2 (ru)
AT (1) AT352726B (ru)
BE (1) BE847973A (ru)
CA (1) CA1077942A (ru)
CH (3) CH624102A5 (ru)
DD (1) DD126942A5 (ru)
DE (1) DE2549999A1 (ru)
DK (1) DK494876A (ru)
FI (1) FI763148A (ru)
FR (1) FR2330678A1 (ru)
GB (1) GB1502050A (ru)
HU (1) HU171237B (ru)
IE (1) IE43866B1 (ru)
IT (1) IT1063618B (ru)
LU (1) LU76141A1 (ru)
NL (1) NL7612286A (ru)
SE (1) SE7612234L (ru)
SU (3) SU633473A3 (ru)
ZA (1) ZA766381B (ru)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5559127A (en) * 1992-10-14 1996-09-24 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0673247A4 (en) * 1992-12-01 1996-05-01 Merck & Co Inc FIBRINOGEN RECEPTOR ANTAGONISTS.
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
WO1997011939A1 (fr) * 1995-09-28 1997-04-03 Kaken Pharmaceutical Co., Ltd. Procede d'elaboration de 4-methylenepiperidines
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
US7888386B2 (en) * 2008-07-24 2011-02-15 Theravance, Inc. 3-(phenoxyphenylmethyl)pyrrolidine compounds
DK2358674T3 (da) 2008-11-14 2013-04-08 Theravance Inc Fremgangsmåde til fremstilling af 4-[2-(2-fluorphenoxymethyl)phenyl]piperidinforbindelser
WO2010120910A1 (en) * 2009-04-15 2010-10-21 Theravance, Inc. 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
MX2012000685A (es) * 2009-07-13 2012-02-28 Theravance Inc Compuesto de 3-fenoximetilpirrolidina.
ES2495366T3 (es) 2009-07-21 2014-09-17 Theravance, Inc. Compuestos de 3-fenoximetilpirrolidina
EP2523945A1 (en) * 2010-01-11 2012-11-21 Theravance, Inc. 1 - (2 - phenoxymethylphenyl) piperazine compounds as serotonin and norepinephrine reuptake inhibitors
ES2543064T3 (es) * 2010-03-22 2015-08-14 Theravance Biopharma R&D Ip, Llc Compuestos de 1-(2-fenoximetilheteroaril)piperidina y piperazina
WO2012051103A1 (en) 2010-10-11 2012-04-19 Theravance, Inc. Serotonin reuptake inhibitors
WO2012075239A1 (en) 2010-12-03 2012-06-07 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE2549999A1 (de) 1977-05-12
DE2549999C2 (ru) 1989-01-26
AT352726B (de) 1979-10-10
ZA766381B (en) 1977-10-26
CH627166A5 (ru) 1981-12-31
HU171237B (hu) 1977-12-28
SU633473A3 (ru) 1978-11-15
ATA823776A (de) 1979-03-15
DK494876A (da) 1977-05-08
DD126942A5 (ru) 1977-08-24
IE43866L (en) 1977-05-07
CH624102A5 (ru) 1981-07-15
CA1077942A (en) 1980-05-20
SU867298A3 (ru) 1981-09-23
FI763148A (ru) 1977-05-08
NL7612286A (nl) 1977-05-10
LU76141A1 (ru) 1977-05-18
SE7612234L (sv) 1977-05-07
CH625788A5 (ru) 1981-10-15
BE847973A (fr) 1977-05-04
JPS5259163A (en) 1977-05-16
FR2330678B1 (ru) 1980-11-07
JPS6055509B2 (ja) 1985-12-05
IT1063618B (it) 1985-02-11
FR2330678A1 (fr) 1977-06-03
GB1502050A (en) 1978-02-22
IE43866B1 (en) 1981-06-17
US4243807A (en) 1981-01-06

Similar Documents

Publication Publication Date Title
SU662009A3 (ru) Способ получени производных пиперидина или их солей
SU575025A3 (ru) Способ получени 4-арил-1,4-дигидропиридинов или их солей
SU549085A3 (ru) Способ получени 1-(3-(нафт-1-илокси)2-оксипропил)-пиперазина или их солей
IL22669A (en) (Alaoxy-low benzamide) -New pyrolidines and piperidines
US4337263A (en) 1-Aryl-4-γ-arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use as hypolipemiant and hypocholesterolemiant agents
SU505355A3 (ru) Способ получени замещенных
US3325505A (en) 4-cycloalkyl(or cycloalkenyl)-dihydropyridines
SU606549A3 (ru) Способ получени фенилалкиламинов или их солей
RU2114105C1 (ru) 4-(4-пиридил)бутиловый эфир n-сульфонилтирозина или его фармацевтически приемлемые соли и способ получения 4-(4-пиперидил)бутилового эфира n-сульфонилтирозина или его фармацевтически приемлемых солей
SU453836A3 (ru) Способ получения производных 3-бензилпиридина или их солей
EP2479166A1 (en) A process for the preparation of etoricoxib
SU535907A3 (ru) Способ получени 1-(4-метил-6окси-2-пиримидинил)-3-метилпиразолин-5-она
SU679136A3 (ru) Способ получени производного пиперидина или его солей
SU520037A3 (ru) Способ получени аминов, их солей, рацематов или оптически-активных антиподов
US5112978A (en) Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol
SU603336A3 (ru) Способ получени эфиров оксимов или их солей
US2490834A (en) Benzhydryl beta hydroxy alkyl amines
SU586840A3 (ru) Способ получени производных 1,4-бензодиоксана
US2987546A (en) Acyl-and amino-substituted phenol ethers
US4350816A (en) Process for the production of 4-amino-6-hydroxy-3-phenyl isoxazolo [5,4-b]p
JP3029901B2 (ja) 新規なメトキシ基導入法による2−ヒドロキシメチル−4−メトキシ−3,5−ジメチルピリジンの製造法
CN112341398B (zh) 具有生物活性的1,2,3-三氮唑取代的查尔酮衍生物、制备方法及其应用
SU656511A3 (ru) Способ получени производных гексагидро-4-индолинола или их солей
US3004976A (en) Aromatic carboxylic acid esters of
SU522794A3 (ru) Способ получени производных -1-фенокси-2-окси-3-аминопропана или их солей